Qube Research & Technologies LTD Regeneron Pharmaceuticals, Inc. Put Options Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2024 Feb 14, 2025	BUY	$701.85 - $1046.91 $13.3 Million - $19.9 Million	19,000 Added 327.59%	24,800 $17.7 Million
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $13.8 Million - $16.2 Million	-13,500 Reduced 69.95%	5,800 $6.1 Million
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $67.1 Million - $81.4 Million	-76,000 Reduced 79.75%	19,300 $20.3 Million
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $81.9 Million - $90.1 Million	90,700 Added 1971.74%	95,300 $91.7 Million
Q4 2023 Feb 13, 2024	SELL	$775.18 - $881.7 $9.84 Million - $11.2 Million	-12,700 Reduced 73.41%	4,600 $4.04 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $12 Million - $14.6 Million	17,300 New	17,300 $14.2 Million

1,485

84.8M

1.51M

1.48M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.